Chrysin
CAS 480-40-0
Chrysin (CAS 480-40-0) is a pharmaceutical compound with 10 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 30906.32671641791 nM | 132 | - |
| - | Potency | 17545.70322580645 nM | 60 | - |
| - | GI50 | 22213.73962962963 nM | 54 | - |
| - | Ki | 8049.7676 nM | 25 | - |
| - | MIC | 83.75 ug.mL-1 | 20 | - |
| - | EC50 | 61315 nM | 6 | - |
| - | AC50 | 4315.536 nM | 5 | - |
| - | IC50 | 10.59 ug.mL-1 | 5 | - |
| - | EC50 | 9.2 ug.mL-1 | 2 | - |
| - | Kd | 11006.255000000001 nM | 2 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| CYP1A1 CYP1A1 |
Inhibition | 7.380000114440918 pKi | 21482471 |
| CYP1B1 CYP1B1 |
Inhibition | 7.800000190734863 pKi | 21482471 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CHRYSIN | 1362888 | SU | MTHSPL |
| chrysin | 1362888 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Chrysin used for in pharmaceutical contexts?
Chrysin (CAS 480-40-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Chrysin?
No adverse-event association or SIDER side-effect rows are rendered for Chrysin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Chrysin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Chrysin with EU status "permitted".
What clinical phase is Chrysin in?
No phase 1-4 clinical development badge is rendered for Chrysin because the matched compound identifier rows do not contain a max-phase value.